Asset Entities (ASST) Competitors $4.28 -0.25 (-5.52%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$4.28 +0.00 (+0.12%) As of 08/15/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ASST vs. HCAT, GMGI, SANG, TRUE, TLS, PERF, TEAD, EGAN, AISP, and HPAIShould you be buying Asset Entities stock or one of its competitors? The main competitors of Asset Entities include Health Catalyst (HCAT), Golden Matrix Group (GMGI), Sangoma Technologies (SANG), TrueCar (TRUE), Telos (TLS), Perfect (PERF), Teads (TEAD), eGain (EGAN), Airship AI (AISP), and Helport AI (HPAI). These companies are all part of the "computer software" industry. Asset Entities vs. Its Competitors Health Catalyst Golden Matrix Group Sangoma Technologies TrueCar Telos Perfect Teads eGain Airship AI Helport AI Health Catalyst (NASDAQ:HCAT) and Asset Entities (NASDAQ:ASST) are both small-cap computer software companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation. Do institutionals and insiders believe in HCAT or ASST? 85.0% of Health Catalyst shares are owned by institutional investors. Comparatively, 5.5% of Asset Entities shares are owned by institutional investors. 2.6% of Health Catalyst shares are owned by insiders. Comparatively, 56.5% of Asset Entities shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, HCAT or ASST? Health Catalyst has a beta of 1.46, suggesting that its stock price is 46% more volatile than the S&P 500. Comparatively, Asset Entities has a beta of 17.31, suggesting that its stock price is 1,631% more volatile than the S&P 500. Do analysts recommend HCAT or ASST? Health Catalyst currently has a consensus price target of $6.18, indicating a potential upside of 111.71%. Given Health Catalyst's stronger consensus rating and higher probable upside, equities analysts clearly believe Health Catalyst is more favorable than Asset Entities.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Health Catalyst 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42Asset Entities 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HCAT or ASST more profitable? Health Catalyst has a net margin of -31.67% compared to Asset Entities' net margin of -996.98%. Health Catalyst's return on equity of -7.21% beat Asset Entities' return on equity.Company Net Margins Return on Equity Return on Assets Health Catalyst-31.67% -7.21% -3.28% Asset Entities -996.98%-246.95%-215.86% Which has preferable earnings & valuation, HCAT or ASST? Asset Entities has lower revenue, but higher earnings than Health Catalyst. Asset Entities is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealth Catalyst$306.58M0.67-$69.50M-$1.51-1.93Asset Entities$630K112.91-$6.39M-$1.94-2.21 Does the media refer more to HCAT or ASST? In the previous week, Health Catalyst had 8 more articles in the media than Asset Entities. MarketBeat recorded 12 mentions for Health Catalyst and 4 mentions for Asset Entities. Asset Entities' average media sentiment score of 0.53 beat Health Catalyst's score of 0.11 indicating that Asset Entities is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Health Catalyst 1 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Asset Entities 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryHealth Catalyst beats Asset Entities on 10 of the 15 factors compared between the two stocks. Get Asset Entities News Delivered to You Automatically Sign up to receive the latest news and ratings for ASST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASST vs. The Competition Export to ExcelMetricAsset EntitiesTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$71.15M$2.63B$22.12B$9.79BDividend YieldN/A1.55%2.82%4.13%P/E RatioN/A22.9927.9125.06Price / Sales112.9191.4266.4390.94Price / CashN/A45.0326.9458.67Price / Book15.296.255.636.18Net Income-$6.39M$33.68M$198.79M$265.11M7 Day Performance30.09%0.34%0.92%4.22%1 Month Performance-16.08%-5.46%-2.46%0.77%1 Year Performance338.52%32.86%27.80%24.69% Asset Entities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASSTAsset Entities0.4667 of 5 stars$4.28-5.5%N/A+351.9%$71.15M$630K0.0011Short Interest ↑HCATHealth Catalyst4.4281 of 5 stars$2.70-4.6%$6.18+129.0%-56.8%$196.97M$306.58M-1.791,500High Trading VolumeGMGIGolden Matrix Group3.8002 of 5 stars$1.33-5.0%$4.00+200.8%-44.4%$195.28M$151.12M-16.631,200Gap UpSANGSangoma Technologies3.2647 of 5 stars$5.81-0.5%$11.00+89.3%+12.6%$193.99M$247.28M-27.67730News CoveragePositive NewsTRUETrueCar2.5159 of 5 stars$1.89-7.8%$3.19+68.7%-35.3%$179.74M$175.60M-5.56440TLSTelos1.2699 of 5 stars$3.87+62.6%$3.94+1.7%+96.8%$174.89M$108.27M-5.16850News CoverageAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumePERFPerfect1.1952 of 5 stars$1.85-4.9%N/AN/A$165.02M$60.20M30.76N/ATrending NewsShort Interest ↑TEADTeads3.2815 of 5 stars$1.70-1.7%$3.97+133.3%N/A$163.14M$889.88M-2.021,020EGANeGain2.2031 of 5 stars$5.58-3.1%$8.50+52.3%-19.5%$157.54M$92.80M62.00690Positive NewsAISPAirship AI2.211 of 5 stars$4.88+1.9%$6.00+23.0%+38.4%$152.54M$23.05M-2.4447Positive NewsHPAIHelport AIN/A$3.96+0.2%N/A-23.6%$146.68M$29.58M0.00N/ANews CoverageGap Up Related Companies and Tools Related Companies Health Catalyst Competitors Golden Matrix Group Competitors Sangoma Technologies Competitors TrueCar Competitors Telos Competitors Perfect Competitors Teads Competitors eGain Competitors Airship AI Competitors Helport AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASST) was last updated on 8/17/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Asset Entities Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Asset Entities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.